Screening for Biomarkers of Osteoarthritis
Recruiting
Observational Study
Osteoarthritis (OA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Osteoarthritis (OA) is the most prevalent degenerative joint disease worldwide, which causes pain, loss of joint function and declined quality of life, and ranks as the leading cause of disability among individuals aged over 60 years. In China, the number of patients with osteoarthritis is projected to exceed 200 million by 2044, resulting in a continuously growing demand for medical resources and…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Aged between 40 and 70 years (inclusive);
2. Joint pain or stiffness lasting for no less than 3 months;
3. Voluntary participation with signed informed consent.
Exclusion Criteria:
1. Combined with other severe joint diseases, such as rheumatoid arthritis, gout, etc.;
2. Su…
Contacts